Date: Feb 14, 2014 Author: press release Source: SB Wire (
click here to go to the source)
Boston, MA -- (SBWIRE) -- 02/14/2014 -- NovaScan, LLC (NovaScan) is a medical technology company. The company's technology measures the electrical properties of materials. It specializes in designing apparatus to detect breast cancer using the electrical properties of tissue. The company provides noninvasive cancer detection devices to the medical community. NovaScan has developed two devices, an in-vivo (FastPath residual cancer probe) and ex-vivo (Electrical Mammogram) to detect breast cancer. Its FastPath Probe is a hand held device that is used by surgeons to detect malignant tissue left in the surgical cavity during surgery. The company's Electrical Mammogram uses the company's proprietary electrical scanning technology as an aid to traditional x-ray mammograms to produce a color picture that depicts anomalies detected in extracted tissue. NovaScan is headquartered in Milwaukee, Wisconsin, the US.
View Full Report Details and Table of Contents
This report is a source for data, analysis and actionable intelligence on the NovaScan, LLC portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.
Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.
Reasons to Get This Report
About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.
